(Q39589821)

13 September 2017

Primaquine to prevent transmission of falciparum malaria (English)

1 reference

13 September 2017

Plasmodium falciparum

0 references

0 references

1 reference

1

Nicholas J White

1 reference

13 September 2017

23 November 2012

1 reference

Lancet Infectious Diseases

13 September 2017

1 reference

13 September 2017

13

1 reference

13 September 2017

2

1 reference

13 September 2017

175-181

1 reference

Artemisinin Resistance in Plasmodium falciparum Malaria

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Effects of artemisinin derivatives on malaria transmissibility.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Nature of the main contaminant in the anti malaria drug primaquine diphosphate: a qualitative isomer analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

The value of plasmoquine as a gametocide in sub-tertian malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Observations on the action of quinine, atebrin and plasmoquine on the gametocytes of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Prophylactic and sporontocidal treatment of chloroquine resistant Plasmodium falciparum from Malaya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Prophylactic and sporontocidal treatment of chloroquine-resistant Plasmodium falciparum from Vietnam.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Effect of primaquine on gametocytes of Plasmodium falciparum in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Transmission-blocking activities of quinine, primaquine, and artesunate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Glucose-6-phosphate dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Consideration of ethics in primaquine therapy against malaria transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

A prospective study evaluating the efficacy of a single, 45-mg dose of primaquine, as a gametocytocidal agent, in patients with Plasmodium falciparum malaria in Mumbai, India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Review: Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Interactions among primaquine, malaria infection and other antimalarials in Thai subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Predictors of severe hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency following exposure to oxidant stresses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

Comparison of the Curative Antimalarial Activities and Toxicities of Primaquine and Its d and l Isomers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970198-6

7 January 2021

10.1016/S1473-3099(12)70198-6

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

23182932